Astrazeneca (AZN) Payout Ratio (2009 - 2026)

Astrazeneca has reported Payout Ratio for 18 years, with the latest figure at 0.0 in Q2 2026.

• On a quarterly basis, Payout Ratio rose 90.23% year-over-year to 0.0 in Q2 2026; TTM through Jun 2026 was 0.47, a 21.14% increase from a year earlier, with the FY2025 full-year figure at 0.92, up 51.43% from the prior year.
• Payout Ratio was 0.0 for Q2 2026 at Astrazeneca, up from 1.07 in the prior quarter.
• The five-year high for Payout Ratio was 0.0 in Q2 2026, with the low at 7.7 in Q1 2022.
• Average Payout Ratio over 5 years is 1.14, with a median of 0.64 recorded in 2025.
• The sharpest annual moves came in 2022 and 2026: Payout Ratio tumbled 386.63% in 2022, then soared 90.23% in 2026.
• Over 5 years, Payout Ratio stood at 7.7 in 2022, then jumped by 99.84% to 0.01 in 2023, then surged by 83.47% to 0.0 in 2024, then soared by 35.51% to 0.0 in 2025, then surged by 69.07% to 0.0 in 2026.
• The last three Payout Ratio figures came in at 0.0 (Q2 2026), 1.07 (Q1 2026), and 0.0 (Q4 2025), per Business Quant data.